Incyte Reports 2019 Fourth Quarter and Year-End Financial Results and Provides 2020 Financial Guidance and Updates on Key Clinical Programs
Go back to Incyte Reports 2019 Fourth Quarter and Year-End Financial Results and Provides 2020 Financial Guidance and Updates on Key Clinical Programs| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 126.75 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $126.75 | 52 Week High | $118.49 | |||
| Open | $126.75 | 52 Week Low | $55.00 | |||
| Day High | $126.75 | P/E | N/A | |||
| Day Low | $126.75 | EPS | $-0.56 | |||
| Volume | 40 | |||||
